论文信息 - Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002). - 字舞流文

Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).

Y. Nishimura | M. Fukuoka | N. Yamamoto | K. Nakagawa | T. Hida | K. Takeda | S. Negoro | N. Katakami | Y. Segawa | K. Tsujino | Y. Ariyoshi | N. Fuwa | K. Hirokawa | M. Kawahara | Masahiro Tanaka